Sinata Koulla‐Shiro

Effectiveness and safety of a generic fixed-dose combination of nevirapine, stavudine, and lamivudine in HIV-1-infected adults in Cameroon: open-label multicentre trial

Christian Laurent, Charles Kouanfack, Sinata Koulla‐Shiro et al. · The Lancet · 2004 · 305 citations · Full text

Pharmacy, Pharmacotherapy, Clinical Pharmacology +13

Dolutegravir-based and low-dose efavirenz-based regimen for the initial treatment of HIV-1 infection (NAMSAL): week 96 results from a two-group, multicentre, randomised, open label, phase 3 non-inferiority trial in Cameroon

Alexandra Calmy, Tamara Tovar-Sanchez, Charles Kouanfack et al. · The Lancet HIV · 2020 · 164 citations

Pharmacy, Infectious Diseases, Pharmacotherapy +14

Prevalence of methicillin—resistant Staphylococcus aureus in eight African hospitals and Malta

C N Kesah, S. Ben Redjeb, T Odugbemi et al. · Clinical Microbiology and Infection · 2003 · 163 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +13

Effect of mobile phone reminders on follow-up medical care of children exposed to or infected with HIV in Cameroon (MORE CARE): a multicentre, single-blind, factorial, randomised controlled trial

Jean Joël Bigna, Jean Jacques Noubiap, Charles Kouanfack et al. · The Lancet Infectious Diseases · 2014 · 118 citations

Public Health, Child Health, Infectious Disease Control +12

Monitoring of HIV viral loads, CD4 cell counts, and clinical assessments versus clinical monitoring alone for antiretroviral therapy in rural district hospitals in Cameroon (Stratall ANRS 12110/ESTHER): a randomised non-inferiority trial

Christian Laurent, Charles Kouanfack, Gabrièle Laborde-Balen et al. · The Lancet Infectious Diseases · 2011 · 97 citations

Public Health, Community Health, Health Sciences +16